Bio-Techne
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Bio-Techne generated cash of $298,981,000, which is more than the previous year. Cash used in financing activities reached the amount of -$122,398,000 last year. Net change in cash is therefore -$28,780,000.
Cash Flow
| 2015 | 139.35M | -426.49M | 31.27M |
|---|---|---|---|
| 2016 | 143.87M | -107.57M | -23.08M |
| 2017 | 143.44M | -305.95M | 189.38M |
| 2018 | 170.36M | -38.71M | -99.18M |
| 2019 | 181.61M | -336.79M | 134.38M |
| 2020 | 205.21M | 27.09M | -183.80M |
| 2021 | 352.16M | -243.51M | -62.55M |
| 2022 | 325.27M | -96.85M | -242.85M |
| 2023 | 254.39M | -265.64M | 22.61M |
| 2024 | 298.98M | -203.03M | -122.39M |
TECH Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 180.57M | 172.56M | 199.09M | 146.62M | 100.88M | 121.99M | 91.61M | 64.23M | 54.53M | 318.56M |
Operating activities | ||||||||||
Net income | 168.07M | 285.44M | 263.09M | 139.58M | 229.29M | 96.07M | 126.15M | 76.08M | 104.47M | 107.73M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 111.71M | 107.23M | 101.06M | 87.74M | 82.73M | 78.17M | 64.46M | 60.03M | 42.76M | 37.22M |
Stock-based compensation expense | 38.04M | 39.23M | 42.18M | 48.98M | 32.36M | 32.28M | 28.24M | 14.63M | 9.43M | 5.95M |
| Deferred income tax benefit | 38.04M | 39.23M | 42.18M | 48.98M | 32.36M | 32.28M | 28.24M | 14.63M | 9.43M | 5.95M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -20.53M | -20.86M | -57.59M | -15.54M | 6.55M | -2.7M | -308.65M | -19.68M | -217.08M | -11.74M |
Inventories | -14.21M | 400K | -32.00M | -7.14M | -14.86M | -13.64M | -13.32M | -732K | -6.62M | -4.71M |
Accounts payable | 25.76M | -7.90M | 12.74M | 19.09M | 10.34M | 6.10M | 5.02M | 5.69M | 8.92M | 2.15M |
Cash generated by operating activities | 298.98M | 254.39M | 325.27M | 352.16M | 205.21M | 181.61M | 170.36M | 143.44M | 143.87M | 139.35M |
Investing activities | ||||||||||
Purchases Of Investments | -5.52M | -20.5M | -25M | -39.68M | -70.18M | -43.47M | -8.57M | -3.06M | 0 | 0 |
Investments In Property Plant And Equipment | -62.87M | -38.24M | -44.90M | -44.30M | -51.74M | -25.41M | -20.93M | -15.17M | -16.89M | -19.90M |
Acquisitions Net | -169.70M | -315.36M | 0 | -225.90M | 1.90M | -289.49M | -46.27M | -293.78M | -91.42M | -420.10M |
Cash generated by investing activities | -203.03M | -265.64M | -96.85M | -243.51M | 27.09M | -336.79M | -38.71M | -305.95M | -107.57M | -426.49M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 321.09M | 110.98M | 0 | 19.17M | 5.25M | 5.45M | 0 |
Payments for dividends | -50.41M | -50.28M | -50.18M | -49.62M | -48.90M | -48.36M | -47.97M | -47.32M | -47.60M | -47.10M |
Repurchases of common stock | -80.04M | -19.56M | -160.95M | -43.17M | -50.11M | -15.40M | 0 | 0 | 0 | 0 |
Repayments of term debt | -31M | 94M | -85.5M | -271.5M | -188.5M | 166.5M | -59.5M | 252M | -58.5M | 68.03M |
Cash used in financing activities | -122.39M | 22.61M | -242.85M | -62.55M | -183.80M | 134.38M | -99.18M | 189.38M | -23.08M | 31.27M |
Net Change In Cash | -28.78M | 8.00M | -26.52M | 52.46M | 45.73M | -21.10M | 30.37M | 27.37M | 9.70M | -264.03M |
Cash at end of period | 151.79M | 180.57M | 172.56M | 199.09M | 146.62M | 100.88M | 121.99M | 91.61M | 64.23M | 54.53M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |